Last reviewed · How we verify
spinal fluid collection
At a glance
| Generic name | spinal fluid collection |
|---|---|
| Sponsor | CHU de Reims |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials (NA)
- National Cancer Institute "Cancer Moonshot Biobank"
- Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia (PHASE2)
- Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
- Collection of Data and Samples From Healthy Donors for Use in Translational Research
- MRI in High-Grade Glioma Patients Undergoing Chemoradiation (NA)
- Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infection (NA)
- Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |